Bristol Myers Squibb Co (CELG-RI) — 8-K Filings

8-K Filings (16)

• Bristol Myers Squibb Issues Over $20 Billion in New Notes — Nov 18, 2025 Risk: medium
  Bristol Myers Squibb Company announced on November 17, 2025, the issuance of new senior notes. These include $3.857 billion in notes due 2038, $4.581 billion du
• Bristol Myers Squibb Files 8-K — Nov 10, 2025 Risk: low
  Bristol Myers Squibb Company filed an 8-K on November 10, 2025, reporting events as of October 31, 2025. The filing includes information on "Other Events" and "
• 8-K Filing — Nov 3, 2025
• Bristol Myers Squibb Reports Officer Changes & Financials — Jul 25, 2025 Risk: medium
  Bristol Myers Squibb Company (BMY) filed an 8-K on July 25, 2025, reporting events as of July 21, 2025. The filing pertains to the departure of directors or cer
• Bristol Myers Squibb Reports on Shareholder Votes — May 7, 2025 Risk: low
  Bristol Myers Squibb Company filed an 8-K on May 7, 2025, reporting on matters submitted to a vote of security holders on May 6, 2025. The filing details variou
• Bristol Myers Squibb Appoints New Chief Medical Officer — Feb 18, 2025 Risk: low
  Bristol Myers Squibb Company announced on February 18, 2025, that its Board of Directors appointed Dr. Samit Hirawat as Executive Vice President and Chief Medic
• Bristol Myers Squibb Files 8-K on Financials — Feb 6, 2025 Risk: low
  Bristol Myers Squibb Company filed an 8-K on February 6, 2025, reporting on its results of operations and financial condition. The filing also includes Regulati
• Bristol Myers Squibb Files 8-K on Financial and Corporate Matters — Jan 13, 2025 Risk: low
  Bristol Myers Squibb Company filed an 8-K on January 13, 2025, reporting on various financial and corporate events. The filing includes information related to t
• Bristol Myers Squibb Elects New Directors, Updates CFO Compensation — Jun 18, 2024 Risk: low
  Bristol Myers Squibb Company announced on June 18, 2024, changes in its board of directors and executive compensation. Specifically, the company elected two new
• Bristol Myers Squibb Files 8-K on Shareholder Votes & Financials — May 9, 2024 Risk: low
  Bristol Myers Squibb Company filed an 8-K on May 7, 2024, reporting on matters submitted to a vote of security holders and financial statements. The filing also
• Bristol Myers Squibb Files 8-K with Financial Updates — Mar 18, 2024 Risk: low
  Bristol Myers Squibb Company filed an 8-K on March 18, 2024, reporting on "Other Events" and "Financial Statements and Exhibits." The filing includes details ab
• Bristol-Myers Squibb Files 8-K on Debt and Contingent Value Rights — Feb 22, 2024 Risk: medium
  Bristol-Myers Squibb Company filed an 8-K on February 22, 2024, reporting an event that occurred on February 14, 2024. The filing pertains to 'Other Events' and
• Bristol Myers Squibb Reports Officer Changes, Compensation Arrangements — Feb 15, 2024 Risk: medium
  Bristol-Myers Squibb Company filed an 8-K on February 15, 2024, reporting events that occurred on February 13, 2024. The filing indicates changes related to the
• Bristol-Myers Squibb Files Routine 8-K on Securities Status — Feb 14, 2024 Risk: low
  Bristol-Myers Squibb Company filed an 8-K on February 14, 2024, reporting "Other Events" and "Financial Statements and Exhibits." The filing specifically refere
• Bristol-Myers Squibb 8-K: Financial Condition & Operations Update — Feb 2, 2024
  Bristol-Myers Squibb Company filed an 8-K on February 2, 2024, to report on its financial condition and operations, specifically mentioning its Common Stock ($0
• Bristol-Myers Squibb Registers Securities on NYSE — Jan 8, 2024
  Bristol-Myers Squibb Company filed an 8-K on January 8, 2024, to register its Common Stock ($0.10 Par Value), 1.000% Notes due 2025 (BMY25), and 1.750% Notes du

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX